Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.35M Buy
9,514
+261
+3% +$93K 1.48% 14
2025
Q4
$3.03M Buy
9,253
+123
+1% +$39K 1.35% 15
2025
Q3
$2.58M Buy
9,130
+327
+4% +$94.8K 1.17% 19
2025
Q2
$2.46M Sell
8,803
-326
-4% -$92.4K 1.22% 15
2025
Q1
$2.84M Buy
9,129
+66
+0.7% +$19.5K 1.54% 14
2024
Q4
$2.36M Sell
9,063
-153
-2% -$45.4K 1.28% 16
2024
Q3
$2.97M Sell
9,216
-111
-1% -$36.3K 1.64% 11
2024
Q2
$2.91M Buy
9,327
+1,417
+18% +$416K 1.71% 11
2024
Q1
$2.25M Buy
7,910
+1,578
+25% +$462K 1.37% 12
2023
Q4
$1.82M Buy
6,332
+2,266
+56% +$617K 1.21% 15
2023
Q3
$1.09M Buy
4,066
+305
+8% +$76.1K 0.81% 31
2023
Q2
$835K Buy
3,761
+184
+5% +$42.7K 0.59% 42
2023
Q1
$865K Buy
3,577
+26
+0.7% +$6.38K 0.64% 41
2022
Q4
$933K Sell
3,551
-79
-2% -$21.2K 0.7% 37
2022
Q3
$818K Buy
3,630
+93
+3% +$22.5K 0.68% 38
2022
Q2
$861K Buy
3,537
+175
+5% +$42.9K 0.68% 37
2022
Q1
$812K Buy
3,362
+377
+13% +$86.6K 0.55% 49
2021
Q4
$672K Buy
2,985
+418
+16% +$88.2K 0.44% 64
2021
Q3
$545K Buy
2,567
+86
+3% +$19.8K 0.4% 74
2021
Q2
$604K Buy
2,481
+394
+19% +$96.9K 0.45% 61
2021
Q1
$519K Buy
2,087
+123
+6% +$29.3K 0.44% 67
2020
Q4
$452K Buy
+1,964
New +$453K 0.44% 65

Other funds holding AMGN

Patron Partners's AMGN Position: Q1 2026 in Review

Patron Partners increased its Amgen (AMGN) stake by 2.8% in Q1 2026, buying an estimated $93K and bringing the position to 9,514 shares worth $3.35M. The position accounts for 1.48% of the portfolio, ranked #14.

Patron Partners first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Patron Partners held 9,514 shares of Amgen worth $3.35M as of Q1 2026.
  • Patron Partners bought 261 Amgen shares in Q1 2026, an estimated $93K.
  • Amgen made up 1.48% of Patron Partners's portfolio in Q1 2026, its #14 holding.
  • Patron Partners first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Patron Partners's 13F filing for Q1 2026, filed 29 Apr 2026.